Emesis Bag Market Size, By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), By Statistics, Trends, Outlook and Forecast 2026 to 2033 (Financial Impact Analysis)

Emesis Bag Market Size

The Emesis Bag Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8% between 2026 and 2033. The market is estimated at USD 425.5 Million in 2026 and is projected to reach USD 629.8 Million by the end of the forecast period in 2033. This consistent growth is primarily driven by an increasing global awareness of hygiene and infection control, coupled with the rising prevalence of conditions inducing nausea and vomiting across diverse demographic groups. Factors such as expanded healthcare infrastructure, a surge in medical procedures requiring post-operative care, and enhanced preparedness for public health emergencies are significant contributors to this upward trajectory, solidifying the market's robust expansion over the coming years.

Emesis Bag Market introduction

The Emesis Bag Market encompasses the global production, distribution, and consumption of specialized containment solutions designed to provide hygienic and convenient management of vomit or emesis. These bags are engineered to prevent spills, reduce the spread of pathogens, and offer a discreet means for individuals experiencing nausea and vomiting due to various medical conditions, motion sickness, or other environmental factors. Their utility spans a broad spectrum of applications, from critical healthcare settings like hospitals, clinics, and emergency medical services to more common scenarios such as travel, home care, and even public spaces, reflecting their versatile demand in maintaining sanitary environments and patient comfort. The design often incorporates features like wide, rigid openings, secure closure mechanisms, and measurement markings, enhancing user experience and clinical efficacy.

Product descriptions typically highlight the material composition, which can range from various types of plastic, such as polyethylene and polypropylene, to increasingly popular biodegradable alternatives like polylactic acid (PLA) and starch-based polymers. These materials are chosen for their durability, leak-proof properties, and sometimes for their environmental footprint. Major applications of emesis bags include use in chemotherapy treatment centers where patients frequently experience nausea, post-operative recovery rooms, ambulances for emergency transport, and maternity wards. Beyond medical facilities, they are indispensable for individuals prone to motion sickness during car, air, or sea travel, and for managing symptoms associated with viral infections or food poisoning in home settings, providing an essential tool for immediate and discreet waste collection.

The benefits of emesis bags are manifold, contributing significantly to both patient well-being and operational efficiency in healthcare. They minimize exposure to bodily fluids, thereby reducing the risk of cross-contamination and the spread of infectious diseases, which is a paramount concern in clinical environments. For patients, they offer a sense of dignity and control during episodes of sickness, making unpleasant experiences more manageable. For caregivers, these bags simplify cleanup procedures, save time, and reduce the need for extensive sanitization, optimizing staff workflow. Driving factors for market growth include the rising global incidence of chronic diseases, an aging population more susceptible to nausea-inducing conditions, increasing travel and tourism activities, and a heightened public and institutional emphasis on hygiene standards, further propelled by global health crises which underscore the importance of readily available containment solutions.

Emesis Bag Market Executive Summary

The Emesis Bag Market is experiencing robust expansion, propelled by evolving healthcare paradigms, increasing global travel, and a pervasive focus on sanitation and infection control. Key business trends indicate a shift towards advanced material science, with manufacturers investing heavily in developing biodegradable and eco-friendly emesis bags to address growing environmental concerns and regulatory pressures. Furthermore, there's a discernible trend towards product innovation, focusing on enhanced user comfort, improved spill containment mechanisms, and integrated functionalities such as odor absorption. The market is also witnessing a surge in partnerships between manufacturers and healthcare providers, alongside strategic mergers and acquisitions aimed at consolidating market share and expanding product portfolios. Digitalization of supply chains and direct-to-consumer sales channels are also emerging as significant business strategies, leveraging e-commerce platforms to reach a wider customer base and streamline distribution.

Regionally, North America and Europe currently dominate the market, characterized by advanced healthcare infrastructures, high healthcare expenditure, and a strong emphasis on patient safety and hygiene protocols. These regions exhibit mature markets with steady demand, driven by a high prevalence of chronic illnesses and extensive travel activities. However, the Asia Pacific region is rapidly emerging as a high-growth market, attributed to its burgeoning population, improving healthcare access, increasing disposable incomes, and the expansion of medical tourism. Latin America, the Middle East, and Africa are also poised for substantial growth, driven by developing healthcare systems, rising awareness of hygiene, and increasing investments in public health initiatives. Each region presents unique opportunities and challenges, influencing market strategies concerning product localization, pricing, and distribution channels to effectively cater to diverse consumer needs and regulatory environments.

In terms of segmentation, the disposable emesis bag segment holds the largest market share due to its convenience and superior hygiene properties, particularly in clinical settings where infection control is paramount. However, the reusable segment is projected to experience moderate growth, driven by environmental sustainability initiatives and cost-effectiveness in certain applications. Material-wise, plastic-based bags still lead, but there is a significant uptake in biodegradable materials as environmental regulations become stricter and consumer preferences shift towards sustainable options. By application, hospitals and clinics remain the primary end-users, yet the homecare and travel & transportation segments are witnessing accelerated growth, reflecting the broader utility of these products. Distribution channels are also diversifying, with a growing prominence of online sales alongside traditional retail and institutional procurement, showcasing a dynamic market landscape shaped by innovation, sustainability, and evolving consumer behavior.

AI Impact Analysis on Emesis Bag Market

The integration of Artificial Intelligence (AI) within the Emesis Bag Market, while perhaps not immediately obvious, holds significant transformative potential, primarily focusing on operational efficiencies, supply chain optimization, and indirectly, patient care improvements. Common user questions often revolve around how AI could streamline inventory management for healthcare facilities, predict demand fluctuations based on disease outbreaks or travel patterns, or even contribute to the development of 'smart' medical devices that monitor patient health and anticipate needs. Users are concerned about whether AI could lead to more personalized healthcare support, how it might influence manufacturing processes to reduce costs or improve product features, and the ethical implications of data collection. The overarching expectation is that AI could make the market more responsive, efficient, and potentially lead to innovations that enhance the utility and sustainability of emesis bags, albeit through indirect applications within broader healthcare and logistics ecosystems.

• Predictive Demand Forecasting: AI algorithms can analyze historical sales data, seasonal travel trends, public health advisories, and real-time disease outbreak information to accurately predict demand for emesis bags. This optimization minimizes stockouts in critical healthcare environments and reduces overstocking, leading to significant cost savings for manufacturers and distributors while ensuring product availability during peak needs.
• Supply Chain Optimization: AI-powered logistics can enhance the efficiency of the entire supply chain, from raw material procurement to final product delivery. This includes route optimization, warehouse management, and automated inventory replenishment, ensuring timely and cost-effective distribution, especially vital for emergency medical services and large hospital networks.
• Manufacturing Process Enhancement: AI can be employed in smart factories to monitor production lines, predict equipment failures, optimize material usage, and ensure quality control in the manufacturing of emesis bags. This leads to reduced waste, higher production efficiency, and consistent product quality, particularly important for specialized medical devices.
• Smart Healthcare Systems Integration: While not directly embedded in emesis bags, AI can power hospital management systems that track medical supplies, including emesis bags, and integrate with patient care platforms. This allows for automated reordering based on patient admissions, procedural schedules, and specific ward needs, creating a more seamless and responsive supply flow within healthcare facilities.
• Research and Development of Advanced Materials: AI can accelerate the discovery and testing of new materials for emesis bags, particularly in the realm of biodegradable and highly absorbent polymers. Machine learning can analyze material properties and simulate performance under various conditions, speeding up the development cycle for more sustainable and effective product innovations.

DRO & Impact Forces Of Emesis Bag Market

The Emesis Bag Market is significantly influenced by a dynamic interplay of drivers, restraints, opportunities, and broader impact forces, collectively shaping its trajectory. Key drivers include the escalating global prevalence of medical conditions that induce nausea and vomiting, such as cancer (chemotherapy-induced nausea), surgical recovery, pregnancy-related morning sickness, and infectious diseases. The increasing adoption of rigorous hygiene standards in healthcare facilities, coupled with a heightened public awareness regarding infection control, further propels demand for disposable, single-use emesis bags. Moreover, the growth in global travel and tourism, which inherently increases the incidence of motion sickness, and the expansion of emergency medical services infrastructure worldwide are substantial drivers. These factors collectively contribute to a robust and expanding user base across diverse settings, from clinical to personal use, underpinning sustained market growth and innovation.

However, the market also faces notable restraints, primarily stemming from environmental concerns. The vast majority of emesis bags are traditionally made from non-biodegradable plastics, contributing to landfill waste and plastic pollution, which attracts increasing scrutiny from environmental advocacy groups and regulatory bodies. This concern drives up the demand for, and R&D into, eco-friendly alternatives, but these often come with higher production costs, potentially restraining market growth in price-sensitive segments. Additionally, the availability of traditional alternatives like washbasins or reusable containers, especially in lower-income settings, can limit market penetration. Public perception and cultural practices regarding waste disposal also play a role, influencing the adoption rates of disposable medical supplies and presenting challenges for market expansion in certain geographical areas.

Despite these restraints, significant opportunities abound for market players. The burgeoning demand for biodegradable and compostable emesis bags presents a substantial avenue for innovation and market differentiation, aligning with global sustainability goals and consumer preferences. The expansion of home healthcare services and the aging global population create a growing market for accessible and user-friendly emesis solutions for long-term care. Furthermore, technological advancements in material science offer opportunities to develop bags with enhanced features, such as improved odor containment, increased absorbency, and integrated anti-spill mechanisms. Strategic collaborations with healthcare providers, airlines, and public transport systems can unlock new distribution channels and market segments, capitalizing on the ever-present need for convenient and hygienic solutions. The collective impact forces, including stringent healthcare regulations, fluctuating raw material prices, evolving consumer health awareness, and the ongoing threat of infectious disease outbreaks, continuously shape market dynamics, pushing for resilience, innovation, and adaptive supply chain strategies to meet global demands effectively.

Segmentation Analysis

The Emesis Bag Market is comprehensively segmented to provide a granular understanding of its diverse components, allowing for targeted strategic planning and detailed market analysis. This segmentation helps identify specific market niches, consumer preferences, and growth opportunities across different product types, materials, capacities, end-user applications, and distribution channels. The intricate breakdown reveals patterns in demand and supply, highlighting areas of high potential and competitive intensity, thereby assisting stakeholders in optimizing product development, marketing, and distribution strategies to cater effectively to the heterogeneous needs of the global market.

• By Type
  • Disposable Emesis Bags: These are designed for single-use, offering maximum hygiene and reducing the risk of cross-contamination. They are widely preferred in hospitals, clinics, and emergency medical services where infection control is paramount. Their convenience and ease of disposal contribute to their dominant market share.
  • Reusable Emesis Bags: Less common in clinical settings, these bags are typically made from more durable, washable materials. They cater to specific niches, such as personal home use for individuals with chronic conditions or those prioritizing environmental sustainability and cost-effectiveness over single-use convenience, although they require careful sanitization after each use.
• By Material
  • Plastic-based Emesis Bags: Primarily made from polyethylene (PE), polypropylene (PP), or combinations thereof, these materials offer excellent leak-proof properties, durability, and cost-effectiveness. They currently represent the largest segment due to their widespread availability and established manufacturing processes, providing reliable containment for medical and personal use.
  • Biodegradable/Compostable Emesis Bags: Crafted from environmentally friendly materials such as polylactic acid (PLA), starch-based polymers, or other plant-derived compounds. This segment is experiencing rapid growth due to increasing environmental awareness, stringent plastic waste regulations, and consumer demand for sustainable products, offering a guilt-free disposal option.
• By Capacity
  • Small Capacity (e.g., up to 500 ml): Ideal for children, short-term nausea episodes, or situations requiring minimal containment. These are compact and easily portable, often found in personal travel kits or for quick, discreet use.
  • Medium Capacity (e.g., 500 ml - 1000 ml): The most common capacity, suitable for general adult use in healthcare settings, during chemotherapy, or for managing moderate episodes of vomiting. They strike a balance between portability and sufficient containment volume.
  • Large Capacity (e.g., over 1000 ml): Designed for severe or prolonged episodes of emesis, often utilized in critical care, post-surgical recovery, or situations where a larger volume of containment is anticipated. These offer extended use without immediate need for disposal.
• By Application/End-user
  • Hospitals & Clinics: This is the largest end-user segment, including general hospitals, specialized clinics, emergency rooms, surgical centers, and recovery wards. Emesis bags are indispensable for patient care, hygiene, and infection control in these professional medical environments.
  • Emergency Medical Services (EMS): Paramedics and first responders extensively use emesis bags in ambulances and during patient transport to manage acute episodes of vomiting, ensuring a sanitary environment and minimizing hazards during critical interventions.
  • Homecare Settings: As home healthcare trends rise, emesis bags are increasingly used by patients managing chronic illnesses, post-operative recovery at home, or temporary conditions like flu, providing dignity and convenience in a non-clinical setting.
  • Travel & Transportation: Airlines, cruise ships, buses, and private vehicles utilize emesis bags to cater to passengers experiencing motion sickness, offering a discreet and hygienic solution that enhances passenger comfort and maintains vehicle cleanliness.
  • Chemotherapy Centers: Patients undergoing chemotherapy frequently experience severe nausea and vomiting, making emesis bags an essential item for comfort and managing side effects throughout their treatment sessions.
  • Dental Clinics: Used for patients experiencing gag reflexes or nausea during dental procedures, contributing to a more comfortable and hygienic experience for both patient and dental professional.
• By Distribution Channel
  • Online Retail: E-commerce platforms, including major online marketplaces and specialized medical supply websites, offer convenience, a wide product range, and competitive pricing, appealing to individual consumers and smaller healthcare practices. This channel is growing rapidly.
  • Offline Retail (Pharmacies, Supermarkets): Traditional brick-and-mortar pharmacies and supermarkets provide immediate access to emesis bags for general public needs, often for motion sickness or minor ailments, leveraging direct consumer access and trust.
  • Institutional/Direct Sales: This channel involves direct procurement by large hospitals, healthcare systems, government agencies, and emergency services from manufacturers or major medical distributors through tenders and bulk purchasing agreements, ensuring consistent supply for high-volume users.

Value Chain Analysis For Emesis Bag Market

The value chain for the Emesis Bag Market begins with the upstream activities centered on the procurement and processing of raw materials. This initial stage involves sourcing various types of plastics such as polyethylene and polypropylene granules, or increasingly, biodegradable polymers like PLA, starch-based resins, and other compostable materials. Key suppliers in this segment are typically large petrochemical companies or specialized bio-polymer producers. The quality and cost-effectiveness of these raw materials directly impact the final product's performance, durability, and environmental footprint, making strong supplier relationships and efficient material acquisition critical. Research and development efforts at this stage focus on enhancing material properties, such as barrier strength, flexibility, odor control, and biodegradability, to meet evolving market demands and regulatory standards. Effective management of upstream logistics, including transportation and storage of these raw materials, is crucial for maintaining production schedules and cost efficiencies.

Moving downstream, the value chain progresses through manufacturing, assembly, and quality control processes. This midstream segment is where raw materials are transformed into finished emesis bags through various manufacturing techniques, including extrusion, injection molding, and heat sealing. Manufacturers focus on design innovation, such as developing wider, rigid openings for ease of use, secure closure mechanisms to prevent spills, and integrated absorbent pads for enhanced hygiene. Production efficiency, economies of scale, and adherence to stringent medical device manufacturing standards (e.g., ISO 13485) are paramount here to ensure product safety, efficacy, and competitiveness. Packaging, labeling, and sterilization (for certain medical-grade products) also occur at this stage, preparing the products for distribution. Manufacturers often seek to integrate vertical processes or form strategic alliances to optimize production costs and maintain intellectual property related to unique product features and material formulations.

The final stage of the value chain involves distribution channels, connecting manufacturers to end-users through a mix of direct and indirect approaches. Direct distribution typically involves manufacturers selling directly to large institutional clients like hospital networks, government healthcare systems, and emergency medical services through dedicated sales forces and bulk purchasing agreements. This channel allows for greater control over pricing, customer relationships, and service delivery. Indirect distribution, on the other hand, leverages intermediaries such as medical distributors, wholesalers, pharmacies, and increasingly, online retail platforms. Medical distributors play a crucial role in reaching a fragmented market of smaller clinics, individual practitioners, and homecare providers. Online platforms offer extensive reach to individual consumers and smaller businesses, providing convenience and competitive pricing. The choice of distribution channel often depends on the target segment, geographical reach, and logistical capabilities. An optimized distribution network ensures timely product availability, reduces inventory costs, and effectively caters to the diverse needs of the Emesis Bag Market, from critical care facilities to everyday travelers.

Emesis Bag Market Potential Customers

The Emesis Bag Market caters to a wide and diverse range of end-users and buyers, spanning professional healthcare environments, emergency services, personal home care, and the travel industry, among others. In the healthcare sector, primary customers include hospitals, clinics, and specialized medical facilities such as oncology centers, surgical recovery units, and maternity wards. These institutions procure emesis bags in bulk to ensure patient comfort, maintain stringent hygiene standards, and minimize the risk of infection spread within their premises. Healthcare professionals, including doctors, nurses, and medical assistants, are direct users who rely on these bags for efficient patient management during episodes of nausea and vomiting, requiring products that are reliable, easy to use, and meet specific clinical requirements. The demand from these professional settings is consistently high due to the continuous flow of patients experiencing various medical conditions.

Beyond traditional hospital settings, emergency medical services (EMS) providers, including ambulance crews and paramedics, represent a significant customer segment. In critical and often unpredictable situations, emesis bags are indispensable tools for managing patient symptoms during transport, ensuring cleanliness and dignity in confined spaces. Similarly, nursing homes and long-term care facilities are crucial buyers, as their residents, often elderly or with chronic illnesses, frequently experience conditions requiring emesis management. The increasing trend towards home healthcare also broadens the customer base to individual patients and their caregivers. These consumers purchase emesis bags for personal use, managing symptoms from chemotherapy, pregnancy-related sickness, post-operative recovery, or general ailments like stomach flu in the comfort and privacy of their homes, valuing discretion, convenience, and ease of disposal.

The travel and transportation sector constitutes another substantial segment of potential customers. Airlines, cruise lines, bus companies, and even private vehicle owners purchase emesis bags to provide for passengers who may suffer from motion sickness or unforeseen illness during transit. This ensures a more comfortable journey for passengers and simplifies cleanup operations for operators, upholding hygiene standards in public and private transport. Additionally, dental clinics use emesis bags for patients who experience gag reflexes or nausea during procedures, enhancing the patient experience. The growing awareness about personal hygiene and disease prevention further expands the market to the general public, who may purchase emesis bags for preparedness during travel, at-home emergencies, or for individuals prone to frequent bouts of sickness, illustrating the broad utility and essential nature of this product across numerous demographic and professional landscapes.

Emesis Bag Market Key Technology Landscape

The Emesis Bag Market, while seemingly simple, benefits significantly from advancements in material science, design engineering, and manufacturing processes, constituting a dynamic technology landscape. A primary area of innovation lies in the development of sophisticated polymer materials. Traditional emesis bags rely on robust, leak-proof plastics such as polyethylene and polypropylene, which have seen continuous improvements in film strength, puncture resistance, and flexibility through advanced polymer blends and extrusion techniques. More recently, the focus has shifted dramatically towards biodegradable and compostable polymers. Technologies like polylactic acid (PLA) derived from renewable resources, starch-based bioplastics, and other plant-derived polymers are gaining traction. These materials require specialized processing techniques to ensure they retain essential properties like fluid containment and durability while allowing for environmentally responsible disposal, representing a significant technological leap in sustainability.

Beyond material composition, design engineering plays a crucial role in enhancing the functionality and user experience of emesis bags. Innovations include the development of wider, semi-rigid openings that are easier to use for patients, especially those with limited mobility or in distress, minimizing spillage. Advanced closure mechanisms, such as secure twist-and-lock seals or self-sealing valves, are designed to prevent leaks and contain odors effectively after use, which is critical for hygiene and discreet disposal. Some modern designs incorporate internal absorbent pads or gelling agents that solidify liquid contents, further improving containment and reducing the risk of accidental spills or splashes. These design enhancements are driven by extensive research into human factors, ergonomic principles, and clinical feedback, aiming to create products that are intuitive, safe, and maximize patient dignity and comfort in various usage scenarios.

Manufacturing technologies also contribute to the market's evolving landscape, focusing on high-volume production efficiency, cost reduction, and quality consistency. Automated production lines leverage precision machinery for film extrusion, bag formation, sealing, and packaging, ensuring uniformity and adherence to strict medical device quality standards. Robotics and advanced sensor technologies are increasingly employed for quality control, detecting defects and ensuring the integrity of each bag. Furthermore, sterilization techniques, such as ethylene oxide or gamma irradiation, are vital for medical-grade emesis bags to ensure they meet aseptic requirements for use in sensitive healthcare environments. The integration of these material, design, and manufacturing technologies collectively drives the market towards more effective, user-friendly, and environmentally responsible emesis bag solutions, continually adapting to healthcare needs and environmental mandates.

Regional Highlights

• North America: This region stands as a dominant force in the Emesis Bag Market, characterized by its highly developed healthcare infrastructure, substantial healthcare expenditure, and a strong emphasis on patient safety and infection control protocols. The high prevalence of chronic diseases, a significant aging population, and a robust travel and tourism sector consistently fuel demand. Leading market players based in the U.S. and Canada invest heavily in R&D, driving innovation in product design and materials, including an increasing focus on sustainable options. Regulatory frameworks, such as those set by the FDA, ensure high product quality and safety, reinforcing consumer and institutional trust. The extensive network of hospitals, clinics, and emergency medical services, coupled with widespread health awareness campaigns, ensures a consistent and growing market for both medical and personal use of emesis bags.
• Europe: The European market for emesis bags is mature and robust, driven by universal healthcare systems, a large elderly population, and a strong cultural emphasis on public health and hygiene. Countries like Germany, the UK, and France are significant contributors, with strict medical device regulations (e.g., MDR) ensuring high standards for product manufacturing and quality. There's a pronounced trend towards eco-friendly and biodegradable solutions across Europe, influenced by stringent environmental policies and growing consumer demand for sustainable products. High international travel volumes and a well-established pharmaceutical industry, which frequently generates demand from patients undergoing treatments causing nausea, further support market expansion. Strategic collaborations between manufacturers and healthcare providers are common, focusing on integrated solutions for patient care and waste management.
• Asia Pacific (APAC): The APAC region is poised for the most rapid growth in the Emesis Bag Market, primarily due to its massive population, improving economic conditions, and the fast-paced development of healthcare infrastructure in emerging economies like China, India, and Southeast Asian countries. Increasing disposable incomes, rising awareness of personal hygiene, and a growing medical tourism industry are key drivers. While cost-effectiveness remains a significant factor, there's a burgeoning demand for quality and innovative products. The rising incidence of chronic diseases, coupled with a large and aging population in countries like Japan, also contributes to market expansion. Local manufacturers are emerging, alongside international players, fostering a competitive landscape. Government initiatives to enhance public health and increase access to basic medical supplies further accelerate market penetration across diverse end-user segments.
• Latin America: The Emesis Bag Market in Latin America is experiencing steady growth, fueled by expanding healthcare access, increasing health awareness, and improvements in emergency medical services across countries like Brazil, Mexico, and Argentina. While still developing compared to North America and Europe, investments in healthcare infrastructure and rising disposable incomes are driving demand for essential medical supplies. Challenges include varying regulatory environments and price sensitivity, which often leads to a preference for more economical product options. However, as medical tourism grows and international healthcare standards are adopted, there is increasing potential for advanced and higher-quality emesis bags. The increasing number of air and road travelers also contributes to the market, requiring solutions for motion sickness and travel-related discomforts.
• Middle East and Africa (MEA): The MEA region presents a mixed but promising outlook for the Emesis Bag Market. Growth is primarily driven by substantial investments in healthcare infrastructure, particularly in the Gulf Cooperation Council (GCC) countries, coupled with an increasing influx of medical tourists. Rising awareness about hygiene, especially post-pandemic, and a growing expatriate population also contribute to demand. In parts of Africa, the market is nascent but shows potential due to improving access to basic healthcare services and increasing initiatives to combat infectious diseases. Challenges include diverse economic conditions, varying healthcare standards, and logistical complexities in distribution. However, as urbanization continues and healthcare systems develop, the demand for effective and hygienic emesis management solutions is expected to grow, offering significant opportunities for market expansion and product localization to suit regional needs.

Top Key Players

• Medline Industries, Inc.
• Graham Medical
• Dynarex Corporation
• Cardinal Health, Inc.
• McKesson Corporation
• B. Braun Melsungen AG
• Teleflex Incorporated
• Sage Products LLC (Stryker Corporation)
• Merit Medical Systems, Inc.
• Healthmark Industries Co., Inc.
• PDI Healthcare, Inc.
• DeRoyal Industries, Inc.
• Fisher Scientific (Thermo Fisher Scientific)
• Ambitex (International Plastics, Inc.)
• ConvaTec Group Plc
• Kimberly-Clark Corporation
• 3M Company
• Johnson & Johnson
• Stryker Corporation
• Smith & Nephew plc

Frequently Asked Questions